Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.62 |
| ▸ | HTR2B | P41595 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.53 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974126 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL30620186 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL30292285 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL29868324 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL9387360 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL1778134 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL2245919 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL2859001 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL9394792 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 | |
| SCHEMBL28106102 | 1.00 | LMNA (0.62) | LMNAMEN1NR1I2CHRM2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108689943-B | Ruthenium-containing supramolecular compound and preparation method and application thereof | 江苏师范大学 | 2021-07-30 | — | — | CN | claimed |
| CN-109939735-A | A kind of phase transfer catalyst and its synthetic method | 湖南科技大学 | 2019-06-28 | — | — | CN | claimed |
| CN-103540157-A | Polymeric metal-complex functional dye containing 2-(2'-pyridyl)benzimidazole D-pi-A type structure and preparation method thereof | UNIV XIANGTAN | 2014-01-29 | — | — | CN | claimed |
| EP-2723750-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | CLAP CO LTD (KR) | 2022-08-10 | — | — | EP | disclosed |
| CN-108689943-B | Ruthenium-containing supramolecular compound and preparation method and application thereof | 江苏师范大学 | 2021-07-30 | — | — | CN | disclosed |
| CN-112940276-A | Ruthenium-containing supramolecular compound and synthesis method and application thereof | 江苏师范大学 | 2021-06-11 | — | — | CN | disclosed |
| EP-2751855-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2020-10-28 | — | — | EP | disclosed |
| WO-2020163479-A1 | ANTIBIOTIC AMMONIUM COMPOUNDS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-08-13 | — | — | WO | disclosed |
| US-10323204-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| US-10323204-B2 | Low viscosity, low volatility lubricating oil basestocks | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| CN-107629047-A | Asymmetric organic small-molecule photovoltaic material based on benzothiadiazole unit and preparation method and application thereof | 大连理工大学 | 2018-01-26 | — | — | CN | disclosed |
| US-20090176995-A1 | Soluble fullerene derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090176995-A1 | Soluble fullerene derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2009-07-09 | — | — | US | disclosed |
| US-7282742-B2 | Organic thin film transistor devices and organic photovoltaic devices | TORAY INDUSTRIES, INC. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20070116984-A1 | SPIRO-COMPOUND FOR ELECTROLUMINESCENT DISPLAY DEVICE AND ELECTROLUMINESCENT DISPLAY DEVICE COMPRISING THE SAME | DOOSAN CORPORATION (KR) | 2007-05-24 | — | — | US | disclosed |
| US-20040241900-A1 | Organic semiconductor material and organic semiconductor element employing the same | TORAY INDUSTRIES, INC. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1449887-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR ELEMENT EMPLOYING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2004-08-25 | — | — | EP | disclosed |
| EP-1109791-A1 | PROCESS FOR MAKING 2-(2-HYDROXY-4-ALKOXYPHENYL)-4,6-BISARYL-1,3,5-TRIAZINES | CYTEC TECHNOLOGY CORP. (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000014075-A1 | PROCESS FOR MAKING 2-(2-HYDROXY-4-ALKOXYPHENYL)-4,6-BISARYL-1,3,5-TRIAZINES | CYTEC TECHNOLOGY CORP. (US) | 2000-03-16 | — | — | WO | disclosed |
| WO-1994029243-A1 | SYNTHESIS OF SUBSTITUTED TRIPHENYLENES, USEFUL AS DISCOTIC LIQUID CRYSTALS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323204-B2 | Low viscosity, low volatility lubricating oil basestocks | TYK2, JAK1, CEL | LMNA 2748/4885MEN1 4145/4885NR1I2 735/4885 |
| US-20090176995-A1 | Soluble fullerene derivatives | SOD1, EPCAM, NDUFV2 | LMNA 3745/4885MEN1 2921/4885NR1I2 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.